Trademark: 97442171
Status Date
Wednesday, January 10, 2024
Filing Date
Friday, June 3, 2022
Published for Opposition
Tuesday, August 8, 2023
Abandoned Date
Tuesday, January 9, 2024
5 Pharmaceutical preparations for cell therapy to treat human diseases and disorders; cell therapy products, namely, pharmaceutical preparations to treat cellular disorders, namely, human diseases and disorders
42 scientific research and development; Scientific research and development in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of new technology in the field of cell therapy; scientific testing, inspection, research, and development of pharmaceutical preparations for cell therapy
Jan 10, 2024
Abandonment Notice E-Mailed - After Publication
Jan 9, 2024
Teas Express Abandonment Received
Jan 10, 2024
Abandonment - After Publication
Aug 21, 2023
Extension Of Time To Oppose Received
Aug 8, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 8, 2023
Published For Opposition
Jul 19, 2023
Notification Of Notice Of Publication E-Mailed
Jul 3, 2023
Approved For Pub - Principal Register
Jun 30, 2023
Teas/Email Correspondence Entered
Jun 29, 2023
Correspondence Received In Law Office
Jun 29, 2023
Teas Response To Office Action Received
Apr 4, 2023
Notification Of Non-Final Action E-Mailed
Apr 4, 2023
Non-Final Action E-Mailed
Apr 4, 2023
Non-Final Action Written
Mar 20, 2023
Assigned To Examiner
Jan 11, 2023
Automatic Update Of Assignment Of Ownership
Jun 14, 2022
New Application Office Supplied Data Entered
Jun 7, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
